↓ Skip to main content

From LBR-101 to Fremanezumab for Migraine

Overview of attention for article published in CNS Drugs, October 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)

Mentioned by

wikipedia
3 Wikipedia pages

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
43 Mendeley
Title
From LBR-101 to Fremanezumab for Migraine
Published in
CNS Drugs, October 2018
DOI 10.1007/s40263-018-0579-4
Pubmed ID
Authors

Marcelo E. Bigal, Alan M. Rapoport, Stephen D. Silberstein, Sarah Walter, Richard J. Hargreaves, Ernesto Aycardi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 43 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 14%
Student > Bachelor 5 12%
Researcher 5 12%
Student > Ph. D. Student 4 9%
Other 3 7%
Other 6 14%
Unknown 14 33%
Readers by discipline Count As %
Medicine and Dentistry 9 21%
Pharmacology, Toxicology and Pharmaceutical Science 7 16%
Nursing and Health Professions 3 7%
Unspecified 2 5%
Agricultural and Biological Sciences 2 5%
Other 5 12%
Unknown 15 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2019.
All research outputs
#7,585,435
of 23,130,383 outputs
Outputs from CNS Drugs
#689
of 1,319 outputs
Outputs of similar age
#135,693
of 346,188 outputs
Outputs of similar age from CNS Drugs
#13
of 19 outputs
Altmetric has tracked 23,130,383 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,319 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,188 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.